Page last updated: 2024-11-12

lepadin f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lepadin F: cis-decahydroquinoline alkaloid from the Australian ascidian Aplidium tabascum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10454883
CHEMBL ID104718
MeSH IDM0425212

Synonyms (3)

Synonym
lepadin f
CHEMBL104718
[(2s,3s,4ar,5r,8as)-5-(5-hydroxyoctyl)-2-methyl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-3-yl] (e)-oct-2-enoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID152152Antiplasmodial activity against Plasmodium falciparum K12002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID21365150% antitrypanosomal activity against Trypanosoma cruzi2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID152165Antiplasmodial activity against Plasmodium falciparum NF542002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID492427Antimalarial activity against Plasmodium falciparum K12009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID21446550% antitrypanosomal activity against Trypanosoma rhodesiense2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID492435Antimalarial activity against multidrug-resistant Plasmodium falciparum NF542009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID71154Zone of inhibition from the edge of a circular filter disk impregnated with test substance, against Eurotium repens (antifungal activity)2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID224142Inhibition of p56 Lck tyrosine kinase at 200 ug/mL2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AID225700Cytotoxic effect in rat skeletal muscle myoblast L6 cells2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]